Effects of hormone therapy on brain morphology of healthy postmenopausal women: a Voxel-based morphometry study

Objective: Estrogens are known to be protective in age-associated cognitive changes in humans and in neurodegeneration in animal models. The aim of this study was to evaluate the potential effects of estrogen therapy (ET) on human gray matter volume in vivo. Design: Forty healthy postmenopausal women underwent three-dimensional high-resolution magnetic resonance imaging: 17 were never treated, 16 were currently receiving ET, and 7 had had ET in the past. Voxel-based morphometry (VBM) with SPM2 was used, according to an optimized protocol, to compare women under past and current ET to those never treated. Significance threshold was set at P = 0.01, corrected by false discovery rate. Results: Voxel-based morphometry indicated that estrogen use was associated with greater gray matter volumes in the whole group of treated women, which included the cerebellum (cluster size, Z coordinates: 5,527; 5.15; −14 −54 −10), the amygdaloid-hippocampal complex (left: 19; 3.55; −22 −4 −18; right: 45; 3.61; 16 −6 −16), and extended to the frontal, temporal, parietal, and occipital neocortex. The comparison current ET versus past ET use showed that women who underwent treatment in the past had greater volumes of gray matter compared to women under current treatment. Conclusions: ET might slow down age-related gray matter loss in postmenopausal women. The structures that exhibited greater volume in association with ET included the cerebellar and cerebral cortices and, typically involved in Alzheimer's disease, the medial temporal structures and the temporoparietal junction.

[1]  N. Bogdanovic,et al.  19‐Nortestosterone influences neural stem cell proliferation and neurogenesis in the rat brain , 2005, The European journal of neuroscience.

[2]  G. Frisoni,et al.  Effects of estrogens on cognition and brain morphology: involvement of the cerebellum. , 2006, Maturitas.

[3]  C. Christiansen,et al.  Early postmenopausal hormone therapy may prevent cognitive impairment later in life , 2005, Menopause.

[4]  J. Rhodin,et al.  In vivo cerebrovascular actions of amyloid beta-peptides and the protective effect of conjugated estrogens. , 2003, Journal of Alzheimer's disease : JAD.

[5]  Thomas E. Nichols,et al.  Nonparametric permutation tests for functional neuroimaging: A primer with examples , 2002, Human brain mapping.

[6]  W. Markesbery,et al.  Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.

[7]  J. Lambert,et al.  The allelic modulation of apolipoprotein E expression by oestrogen: potential relevance for Alzheimer’s disease , 2004, Journal of Medical Genetics.

[8]  D. Murphy,et al.  The Women's Health Initiative Memory Study: findings and implications for treatment , 2005, The Lancet Neurology.

[9]  S. Resnick,et al.  Effects of Hormone Replacement Therapy on Cognitive and Brain Aging , 2001, Annals of the New York Academy of Sciences.

[10]  A. Lbert,et al.  Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease , 2022 .

[11]  Yaakov Stern,et al.  Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease , 1996, The Lancet.

[12]  Karl J. Friston,et al.  Classical and Bayesian Inference in Neuroimaging: Applications , 2002, NeuroImage.

[13]  Y. Hurd,et al.  Estrogen receptors in the human forebrain and the relation to neuropsychiatric disorders , 2001, Progress in Neurobiology.

[14]  D. Krause,et al.  Multiple forms of estrogen receptor-α in cerebral blood vessels: regulation by estrogen , 2003 .

[15]  C. Toran-Allerand.  Estrogen and the brain: beyond ER-α and ER-β , 2004, Experimental Gerontology.

[16]  Roberta Diaz Brinton,et al.  Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons , 2004, Brain Research.

[17]  Arto Mannermaa,et al.  Estrogen receptor beta gene variants are associated with increased risk of Alzheimer's disease in women , 2005, European Journal of Human Genetics.

[18]  M. Rice,et al.  Postmenopausal estrogen and estrogen-progestin use and 2-year rate of cognitive change in a cohort of older Japanese American women: The Kame Project. , 2000, Archives of internal medicine.

[19]  S. Murayama,et al.  Association of Estrogen Receptor α Gene Polymorphisms with Neurofibrillary Tangles , 2004, Dementia and Geriatric Cognitive Disorders.

[20]  H. Semlitsch,et al.  Age-related cognitive decline in the menopause: effects of hormone replacement therapy on cognitive event-related potentials. , 2005, Maturitas.

[21]  B. Tycko,et al.  Onset of dementia is associated with age at menopause in women with Down's syndrome , 2003, Annals of neurology.

[22]  JoAnn E Manson,et al.  Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. , 2004, JAMA.

[23]  W. Markesbery,et al.  Brain infarction and the clinical expression of Alzheimer disease. , 1997, JAMA.

[24]  E. Mufson,et al.  Distribution of estrogen receptor alpha and beta immunoreactive profiles in the postnatal rat brain. , 2003, Brain research. Developmental brain research.

[25]  G. Small,et al.  Estrogen use and brain metabolic change in postmenopausal women , 2004, Neurobiology of Aging.

[26]  J. Janowsky,et al.  Hormone replacement therapy and cognition: systematic review and meta-analysis. , 2001, JAMA.

[27]  D. Krause,et al.  Multiple forms of estrogen receptor-alpha in cerebral blood vessels: regulation by estrogen. , 2003, American journal of physiology. Endocrinology and metabolism.

[28]  S. Murayama,et al.  Association of estrogen receptor alpha gene polymorphisms with neurofibrillary tangles. , 2004, Dementia and geriatric cognitive disorders.

[29]  R. Ravid,et al.  Decreased estrogen receptor-α expression in hippocampal neurons in relation to hyperphosphorylated tau in Alzheimer patients , 2003, Acta Neuropathologica.

[30]  D. Krause,et al.  Estrogen Receptor Activation of Phosphoinositide-3 Kinase, Akt, and Nitric Oxide Signaling in Cerebral Blood Vessels: Rapid and Long-Term Effects , 2005, Molecular Pharmacology.

[31]  Robert B Wallace,et al.  Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. , 2003, JAMA.

[32]  Karl J. Friston,et al.  Classical and Bayesian Inference in Neuroimaging: Theory , 2002, NeuroImage.

[33]  F. Fazekas,et al.  Estrogen Replacement Therapy In Older Women: A Neuropsychological And Brain MRI Study , 1996, Journal of the American Geriatrics Society.

[34]  C. Toran-Allerand.  Estrogen and the brain: beyond ER-alpha and ER-beta. , 2004, Experimental gerontology.

[35]  Estrogen Replacement Therapy and Cognitive Decline in Older Community Women , 1999, Journal of the American Geriatrics Society.

[36]  Brenda L Plassman,et al.  Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. , 2002, JAMA.

[37]  M. Morissette,et al.  Effect of estrogen receptor agonists treatment in MPTP mice: evidence of neuroprotection by an ERα agonist , 2004, Neuropharmacology.

[38]  S. Resnick,et al.  Effects of Estrogen Replacement Therapy on PET Cerebral Blood Flow and Neuropsychological Performance , 1998, Hormones and Behavior.

[39]  N. Inestrosa,et al.  Cellular and molecular basis of estrogen's neuroprotection. Potential relevance for Alzheimer's disease. , 1998, Molecular neurobiology.

[40]  C. Colton,et al.  Sex steroids, APOE genotype and the innate immune system , 2005, Neurobiology of Aging.

[41]  D. Murphy,et al.  In Vivo Effects of Estrogen on Human Brain , 2003, Annals of the New York Academy of Sciences.

[42]  A. Hofman,et al.  Variations in estrogen receptor alpha gene and risk of dementia, and brain volumes on MRI. , 2004, Molecular psychiatry.

[43]  JoAnn E. Manson,et al.  Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. , 2004 .

[44]  A. Kitabatake,et al.  Estrogen Deprivation and Replacement Modulate Cerebral Capillary Density with Vascular Expression of Angiogenic Molecules in Middle-Aged Female Rats , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[45]  E. Gould,et al.  Ovarian steroids influence cell proliferation in the dentate gyrus of the adult female rat in a dose‐ and time‐dependent manner , 2005, The Journal of comparative neurology.

[46]  W. Jagust,et al.  Preliminary evidence that estrogen protects against age-related hippocampal atrophy , 2003, Neurobiology of Aging.